Yugo Chisaki1, Tomohiro Terada2, Yoshitaka Yano3 (1.Kyoto Pharmaceutical University, 2.Shiga University of Medical Science Hospital, 3.Kyoto Pharmaceutical University)
Session information
Poster
[P26-7] P26-7: Oncologic drugs (3): Pharmaometrics, PK/PD, special population
Tue. Sep 26, 2017 12:30 PM - 1:30 PM Annex Hall (1F)
Chair: Shiro Fukumori, Japan
Takumi Maruyama1, Yukihiro Hamada2, Yutaka Fukaya3, Satoshi Yamazaki4, Yujiro Geka5, Kazuhiko Hayashi6, Toshimi Kimura7 (1.Tokyo Women's Medical University Hospital, 2.Tokyo Women's Medical University Hospital, 3.Tokyo Women's Medical University Hospital, 4.Tokyo Women's Medical University Hospital, 5.Tokyo Women's Medical University Hospital, 6.Tokyo Women's Medical University Hospital, 7.Tokyo Women's Medical University Hospital)
Tsuyoshi Aoyama1, Mitsuru Sugawara2, Yoh Takekuma3, Yuki Sato4, Masato Sumi5 (1.Hokkaido University, 2.Hokkaido University, 3.Hokkaido University, 4.Hokkaido University, 5.Hokkaido University)
Shinji Kobuchi1, Yukako Ito2, Toshiyuki Sakaeda3 (1.Kyoto Pharmaceutical Universtiy, 2.Kyoto Pharmaceutical Universtiy, 3.Kyoto Pharmaceutical Universtiy)
Satoshi Noda1, Makoto Shioya2, Hiroya Iida3, Shigeyuki Naka4, Daiki Hira5, Akira Andoh6, Masaji Tani7, Shin-Ya Morita8, Tomohiro Terada9 (1.Shiga University of Medical Science Hospital, 2.Shiga University of Medical Science Hospital, 3.Shiga University of Medical Science Hospital, 4.Shiga University of Medical Science Hospital, 5.Shiga University of Medical Science Hospital, 6.Shiga University of Medical Science Hospital, 7.Shiga University of Medical Science Hospital, 8.Shiga University of Medical Science Hospital, 9.Shiga University of Medical Science Hospital)
Sayo Suzuki1, Yuki Hattori2, Akinori Takagi3, Tohru Aomori4, Hidefumi Kasai5, Tomonori Nakamura6 (1.Keio University, 2.Keio University, 3.Keio University, 4.Keio University, 5.Certara G. K, 6.Keio University)
Taisuke Ezaki1, Kazuhiro Matsumoto2, Shinya Morita3, Kazunobu Shinoda4, Ryuichi Mizuno5, Eiji Kikuchi6, Mototsugu Oya7 (1.Saitama City Hospital, 2.Keio University School of Medicine, 3.Keio University School of Medicine, 4.Keio University School of Medicine, 5.Keio University School of Medicine, 6.Keio University School of Medicine, 7.Keio University School of Medicine)
Tsutomu Nakamura1, Manabu Kume2, Kazuhiko Yamashita3, Midori Hirai4 (1.Osaka University of Pharmaceutical Sciences, 2.Kobe University Hospital, 3.Kobe University Hospital, 4.Kobe University Hospital)
Gerd Ackehed1, Jennie Oestervall2, Anna Hansson3, Anton Pohanka4, Olof Beck5 (1.Karolinska University Laboratory, 2.Karolinska University Laboratory, 3.Karolinska University Laboratory, 4.Karolinska University Laboratory, 5.Karolinska University Laboratory)
Erik van Maarseveen1, Jurgen Langenhorst2, Charlotte van Kesteren3, Thomas Dorlo4, Stefan Nierkens5, Jurgen Kuball6, Moniek de Witte7, Alwin Huitema8, JaapJan Boelens9
(1.University Medical Center Utrecht, 2.University Medical Center Utrecht, 3.University Medical Center Utrecht, 4.Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute
, 5.University Medical Center Utrecht, 6.University Medical Center Utrecht, 7.University Medical Center Utrecht, 8.University Medical Center Utrecht, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, 9.University Medical Center Utrecht)